Evidence map›Paper›PMID 34180656›Full record

ArticleACS nano2021

Babatunde O Okesola, Ana Karen Mendoza-Martinez, Gianluca Cidonio, Burak Derkus, Delali K Boccorh, David Osuna de la Peña, Sherif Elsharkawy, Yuanhao Wu, Jonathan I Dawson, Alastair W Wark and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS nano, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Babatunde O OkesolaInstitute of Bioengineering, Queen Mary University of London, London E1 4NS, U.K.ORCID 0000-0003-0392-9205
Ana Karen Mendoza-MartinezInstitute of Bioengineering, Queen Mary University of London, London E1 4NS, U.K.
Gianluca CidonioBone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton SO16 6YD, U.K.
Burak DerkusInstitute of Bioengineering, Queen Mary University of London, London E1 4NS, U.K.ORCID 0000-0001-5558-0995
Delali K BoccorhDepartment of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow G1 1RD, U.K.
David Osuna de la PeñaSchool of Engineering and Materials Science, Queen Mary University of London, London E1 4NS, U.K.
Sherif ElsharkawyCentre for Oral, Clinical, and Translational Sciences, Faculty of Dentistry, Oral, and Craniofacial Sciences, King's College London, London SE1 1UL, U.K.
Yuanhao WuSchool of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K.
Jonathan I DawsonBone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton SO16 6YD, U.K.ORCID 0000-0002-6712-0598
Alastair W WarkDepartment of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow G1 1RD, U.K.ORCID 0000-0001-8736-7566
Dafna KnaniDepartment of Biotechnology Engineering, ORT Braude College, Karmiel 2161002, Israel.ORCID 0000-0002-9490-2819
Dave J AdamsSchool of Chemistry, College of Science and Engineering, University of Glasgow, Glasgow G12 8QQ, U.K.ORCID 0000-0002-3176-1350
Richard O C OreffoBone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Institute of Developmental Sciences, University of Southampton, Southampton SO16 6YD, U.K.ORCID 0000-0001-5995-6726
Alvaro MataInstitute of Bioengineering, Queen Mary University of London, London E1 4NS, U.K.

Funding

Medical Research Council MR/R015651/1
6 · The paper itself

Abstract

Synthetic nanostructured materials incorporating both organic and inorganic components offer a unique, powerful, and versatile class of materials for widespread applications due to the distinct, yet complementary, nature of the intrinsic properties of the different constituents. We report a supramolecular system based on synthetic nanoclay (Laponite,

Indexed as

Mesenchymal Stem CellsNanofibersDurapatiteHumansHydrogelsRheologyDurapatiteHydrogelsbiomineralizationcoassemblylaponitemulticomponent biomaterialsnanocomposite hydrogelspeptide amphiphilessupramolecular

Identifiers

PMID34180656
PMCPMC8320236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.